PKB/Akt promotes DSB repair in cancer cells through upregulating Mre11 expression following ionizing radiation
- PMID: 20956948
- DOI: 10.1038/onc.2010.467
PKB/Akt promotes DSB repair in cancer cells through upregulating Mre11 expression following ionizing radiation
Abstract
An elevated DNA-repair capacity in cancer cells leads to radiation resistance and severely limits the efficacy of radiation therapy. Activation of Akt is tightly associated with resistance to radiotherapy, and Mre11 protein has important role during the repair of DNA double-strand breaks (DSBs). In this report, our results showed that inhibition of Akt activity impaired the repair of DSBs in CNE2 cells, whereas activated Akt promoted the repair of DSBs in HeLa cells. Knockdown of Mre11 also impaired the process of DSB repair in both these two cell lines. More importantly, we found that Akt could regulate Mre11 expression. Inhibition of Akt activity by small interfering RNA or LY294002 efficiently downregulated the Mre11 expression in CNE2 cells, and transfection with myr-Akt plasmid in HeLa cells upregulated the Mre11 expression. In addition, luciferase reporter analysis revealed that Mre11 reporter activity increased after transfection with myr-Akt1 plasmids, and this myr-Akt1-induced transcriptional activity was blocked in the presence of LY294002. Further study showed GSK3β/β-catenin/LEF-1 pathway was involved in this regulation. Knockdown of β-catenin or LEF-1 led to the downregulation of Mre11, whereas overexpression of β-catenin led to upregulation of Mre11. The chromatin immunoprecipitation assay assay showed β-catenin/LEF-1 heterodimer could directly bind to the promoter of Mre11 in vivo. And the luciferase activity of the pGL3-Mre11 and pGL3-Lef increased in HeLa cells following β-catenin plasmid co-transfected, but was abolished when the LEF-1-binding conserved sequences of Mre11 promoter were mutated. These results together support Akt can upregulate the expression of Mre11 through GSK3β/ β-catenin/LEF pathway to elevate DSB-repair capacity in cancer cells.
Similar articles
-
MRE11 promotes AKT phosphorylation in direct response to DNA double-strand breaks.Cell Cycle. 2011 Jul 1;10(13):2218-32. doi: 10.4161/cc.10.13.16305. Epub 2011 Jul 1. Cell Cycle. 2011. PMID: 21623170
-
DNA-PKcs plays a dominant role in the regulation of H2AX phosphorylation in response to DNA damage and cell cycle progression.BMC Mol Biol. 2010 Mar 6;11:18. doi: 10.1186/1471-2199-11-18. BMC Mol Biol. 2010. PMID: 20205745 Free PMC article.
-
Transactivation of lifeguard (LFG) by Akt-/LEF-1 pathway in MCF-7 and MDA-MB 231 human breast cancer cells.Apoptosis. 2010 Jul;15(7):814-21. doi: 10.1007/s10495-010-0493-9. Apoptosis. 2010. PMID: 20336373
-
Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation.Semin Cancer Biol. 2015 Dec;35:180-90. doi: 10.1016/j.semcancer.2015.07.003. Epub 2015 Jul 17. Semin Cancer Biol. 2015. PMID: 26192967 Review.
-
A New Twist in Protein Kinase B/Akt Signaling: Role of Altered Cancer Cell Metabolism in Akt-Mediated Therapy Resistance.Int J Mol Sci. 2020 Nov 13;21(22):8563. doi: 10.3390/ijms21228563. Int J Mol Sci. 2020. PMID: 33202866 Free PMC article. Review.
Cited by
-
Association between RNF2+P-AKT expression in pretreatment biopsy specimens, and poor survival following radiotherapy in patients with esophageal squamous cell carcinoma.Oncol Lett. 2019 Oct;18(4):3734-3742. doi: 10.3892/ol.2019.10727. Epub 2019 Aug 7. Oncol Lett. 2019. PMID: 31516586 Free PMC article.
-
PI3K Inhibition Augments the Therapeutic Efficacy of a 3a-aza-Cyclopenta[α]indene Derivative in Lung Cancer Cells.Transl Oncol. 2014 Apr;7(2):256-266.e5. doi: 10.1016/j.tranon.2014.02.012. Epub 2014 Mar 4. Transl Oncol. 2014. PMID: 24913674 Free PMC article.
-
Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations.Clin Cancer Res. 2016 Apr 15;22(8):2009-19. doi: 10.1158/1078-0432.CCR-15-2245. Epub 2015 Nov 20. Clin Cancer Res. 2016. PMID: 26589432 Free PMC article.
-
DC120, a novel AKT inhibitor, preferentially suppresses nasopharyngeal carcinoma cancer stem-like cells by downregulating Sox2.Oncotarget. 2015 Mar 30;6(9):6944-58. doi: 10.18632/oncotarget.3128. Oncotarget. 2015. PMID: 25749514 Free PMC article.
-
CoA Synthase (COASY) Mediates Radiation Resistance via PI3K Signaling in Rectal Cancer.Cancer Res. 2020 Jan 15;80(2):334-346. doi: 10.1158/0008-5472.CAN-19-1161. Epub 2019 Nov 8. Cancer Res. 2020. PMID: 31704889 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous